.

Pharmaceutical Business Intelligence

  • Find generic sources and suppliers
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Nitroglycerin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for nitroglycerin?

Nitroglycerin is the generic ingredient in sixteen branded drugs marketed by Abraxis Pharm, Pohl Boskamp, Kremers Urban Pharms, Sanofi Aventis Us, Intl Medication, Hospira, Smith And Nephew, Luitpold, Pfizer Pharms, Novartis, Merck Sharp Dohme, Fougera Pharms Inc, Mylan Technologies, Forest Labs Inc, Parke Davis, Baxter Hlthcare, Valeant Pharms, Valeant Pharms North, Medicis, Rorer, Mist Pharms Llc, Hercon Pharm, Dr Reddys Labs Inc, and Perrigo Israel, and is included in forty-two NDAs. There are four patents protecting this compound and four Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Nitroglycerin has twenty-nine patent family members in sixteen countries.

There are thirty-six drug master file entries for nitroglycerin. Thirty-eight suppliers are listed for this compound. There are three tentative approvals for this compound.

Summary for Generic Name: nitroglycerin

Tradenames:16
Patents:4
Applicants:24
NDAs:42
Drug Master File Entries: see list36
Suppliers / Packagers: see list38
Bulk Api Vendors: see list16
Clinical Trials: see list42
Patent Applications: see list4,086
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:nitroglycerin at DailyMed

Pharmacology for Ingredient: nitroglycerin

Ingredient-typeNitrates
Drug ClassNitrate Vasodilator
Physiological EffectVasodilation

Tentative approvals for NITROGLYCERIN

Applicant Application No. Form Dosage
► Subscribe► SubscribeFilm, Extended Release; Transdermal0.2MG/HR
► Subscribe► SubscribeFilm, Extended Release; Transdermal0.4MG/HR
► Subscribe► SubscribeFilm, Extended Release; Transdermal0.6MG/HR
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
NITROGLYCERIN IN DEXTROSE 5%
nitroglycerin
INJECTABLE;INJECTION071847-001Aug 31, 1990RXNoNo► Subscribe► Subscribe
Merck Sharp Dohme
NITRO-DUR
nitroglycerin
FILM, EXTENDED RELEASE;TRANSDERMAL020145-004Apr 4, 1995RXYesYes► Subscribe► Subscribe
Abraxis Pharm
NITROGLYCERIN
nitroglycerin
INJECTABLE;INJECTION070077-001Dec 13, 1985DISCNNoNo► Subscribe► Subscribe
Merck Sharp Dohme
NITRO-DUR
nitroglycerin
FILM, EXTENDED RELEASE;TRANSDERMAL020145-006Apr 4, 1995RXYesYes► Subscribe► Subscribe
Novartis
TRANSDERM-NITRO
nitroglycerin
FILM, EXTENDED RELEASE;TRANSDERMAL020144-003Feb 27, 1996DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: nitroglycerin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis
TRANSDERM-NITRO
nitroglycerin
FILM, EXTENDED RELEASE;TRANSDERMAL020144-005Feb 27, 19964,849,226► Subscribe
Merck Sharp Dohme
NITRO-DUR
nitroglycerin
FILM, EXTENDED RELEASE;TRANSDERMAL020145-006Apr 4, 19955,186,938► Subscribe
Novartis
TRANSDERM-NITRO
nitroglycerin
FILM, EXTENDED RELEASE;TRANSDERMAL020144-004Feb 27, 19964,849,226► Subscribe
Pohl Boskamp
NITROLINGUAL PUMPSPRAY
nitroglycerin
SPRAY, METERED;SUBLINGUAL018705-002Jan 10, 19975,186,925► Subscribe
Novartis
TRANSDERM-NITRO
nitroglycerin
FILM, EXTENDED RELEASE;TRANSDERMAL020144-003Feb 27, 19964,954,344► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: nitroglycerin

Country Document Number Estimated Expiration
Russian Federation2010142023► Subscribe
Germany202008007318► Subscribe
TaiwanI228989► Subscribe
Canada2299231► Subscribe
World Intellectual Property Organization (WIPO)9917766► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc